Biodesix Pipeline Test Demonstrates Utility in Triaging Patients with Lung Nodules
Independent study data show noninvasive test could eliminate the biopsy needle and reduce both patient anxiety and costs.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Research |
Independent study data show noninvasive test could eliminate the biopsy needle and reduce both patient anxiety and costs.
Read MorePosted by Melissa Mayer | Oct 20, 2018 | Research |
Partners to conduct first study using ctDNA-based minimal residual disease assessment for immunotherapy in the adjuvant non-small cell lung cancer setting.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer |
FDA approval allows use of the Therascreen EGFR RGQ PCR kit as a companion diagnostic for Pfizer’s Vizimpro (dacomitinib) in patients with non-small cell lung cancer.
Read MorePosted by Melissa Mayer | Oct 15, 2018 | Lung Cancer, Melanoma, Software |
The panel accurately and sensitively detects more than 1,600 variants of clinical significance.
Read MorePosted by Melissa Mayer | Oct 14, 2018 | Lung Cancer |
First test for improved IPF diagnosis receives draft local coverage determination through the MolDx program.
Read More